Highest Price/Sales Movers: (LEI, SSN, ARNA, AVNR, NBIX)
July 13th, 2010 at 6:31 am Posted by George Harrison
You’ve got to give these guys credit because they’re actually turning a profit, unlike the majority of U.S. listed stocks. One thing that’s common about these 5 stocks priced so differently is their very high price/sales ratio. Think they deserve their grade?
LEI — 14.94 Price/Sales Ratio
Lucas Energy, Inc. (AMEX: LEI) searches for and produces oil and natural gas in Southern Texas. As of mid-2009 the company owned and operated 29 wells. LEI’s Price to Sales ratio is 14.94. On July 12th 2010, the stock price of LEI closed at $2.30. This is a drop of 22 cents from the previous week’s close of $2.52 (-8.7%).
SSN — 18.47 Price/Sales Ratio
Samson Oil & Gas Limited (AMEX: SSN) owns properties in Wyoming, North Dakota, New Mexico, and Texas. SSN explores, develops, and collects oil and gas deposits in its properties. SSN stock price closed at 89 cents on July 12th 2010. This represents an increase of 4 cents or a gain of 4.7%. SSN’s price to sales ratio is 18.47.
ARNA — 36.89 Price/Sales Ratio
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) is a pharmaceutical company which focuses upon discovering, developing, and selling drugs. ARNA’s specialty is cardiovascular central nervous systems, and metabolic diseases. ARNA’s P/S or price to sales ratio is 36.89. ARNA’s stock price fell 2.3% (-$0.09) on July 12th 2010. The new trading value is $3.79.
AVNR — 72.31 Price/Sales Ratio
AVANIR Pharmaceuticals (NASDAQ: AVNR) operates within the United States and Canada, acquiring, developing, and commercializing new therapies for the treatment of the central nervous system. On July 9th 2010 AVNR closed at $3.53. The stock price rose 21 cents (+5.9%) on July 12th 2010 closing at $3.74. AVNR’s price to sales ratio is 73.31.
NBIX — 105.58 Price/Sales Ratio
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) is a pharmaceutical company that operated within the United States. NBIX discovers, produces, and sells a wide-range of drugs related to endocrine system. NBIX’s stock price rose .02 ,less than a half of a percent, from its close on Friday July 9th of $5.68. The new stock trading price is $5.70. NBIX’s price to sales ratio is 105.58.
